Cargando…
Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
Autores principales: | Ottestad, Anine Larsen, Johansen, Håkon, Halvorsen, Tarje Onsøien, Dai, Hong Yan, Wahl, Sissel Gyrid Freim, Emdal, Elisabeth Fritzke, Grønberg, Bjørn Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360275/ https://www.ncbi.nlm.nih.gov/pubmed/37474938 http://dx.doi.org/10.1186/s12885-023-11173-x |
Ejemplares similares
-
Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023) -
The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021) -
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021) -
Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment
por: Ottestad, Anine Larsen, et al.
Publicado: (2022) -
Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer
por: Halvorsen, Tarje Onsøien, et al.
Publicado: (2020)